Low-dose Mesenchymal Stem Cell Therapy for Discogenic Pain: Safety and Efficacy Results From a 1-year Feasibility Study

Dan Bates1 Melbourne Stem Cell Centre, Box Hill, Victoria, 3128, Australia;2 Magellan Stem Cells, Victoria, Australia;3 Metro Pain Group, Clayton, Victoria, 3168, Australia;4 Monash Clinical Research, Clayton, Victoria, 3168, Australia

David Vivian1 Melbourne Stem Cell Centre, Box Hill, Victoria, 3128, Australia;2 Magellan Stem Cells, Victoria, Australia;3 Metro Pain Group, Clayton, Victoria, 3168, Australia;4 Monash Clinical Research, Clayton, Victoria, 3168, Australia

Julien Freitag1 Melbourne Stem Cell Centre, Box Hill, Victoria, 3128, Australia;2 Magellan Stem Cells, Victoria, Australia;5 School of Dentistry & Medical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia

https://orcid.org/0000-0001-6701-4368

James Wickham5 School of Dentistry & Medical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia

Bruce Mitchell1 Melbourne Stem Cell Centre, Box Hill, Victoria, 3128, Australia;2 Magellan Stem Cells, Victoria, Australia;3 Metro Pain Group, Clayton, Victoria, 3168, Australia;4 Monash Clinical Research, Clayton, Victoria, 3168, Australia

Paul Verrills1 Melbourne Stem Cell Centre, Box Hill, Victoria, 3128, Australia;2 Magellan Stem Cells, Victoria, Australia;3 Metro Pain Group, Clayton, Victoria, 3168, Australia;4 Monash Clinical Research, Clayton, Victoria, 3168, Australia

Kiran Shah2 Magellan Stem Cells, Victoria, Australia

Richard Boyd6 The Hudson Institute, Clayton, Victoria, 3168, Australia

Dean Federman7 Capital Radiology, Clayton, Victoria, 3168, Australia

Adele Barnard4 Monash Clinical Research, Clayton, Victoria, 3168, Australia

Lera O'Connor4 Monash Clinical Research, Clayton, Victoria, 3168, Australia

Jacqui F Young4 Monash Clinical Research, Clayton, Victoria, 3168, AustraliaCorrespondence[email protected]

show all

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Low-dose Mesenchymal Stem Cell Therapy for Discogenic Pain: Safety and Efficacy Results From a 1-year Feasibility Study

Articles from other publishers (6)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Low-dose Mesenchymal Stem Cell Therapy for Discogenic Pain: Safety and Efficacy Results From a 1-year Feasibility Study

Citations (6)

Articles from other publishers (6)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date